Literature DB >> 16865647

Genotype-phenotype correlations in Hungarian patients with hereditary medullary thyroid cancer.

Attila Patocs1, Izabella Klein, Aniko Szilvasi, Peter Gergics, Miklos Toth, Zsuzsa Valkusz, Erzsebet Forizs, Peter Igaz, Yousuf Al-Farhat, Attila Tordai, Andras Varadi, Karoly Racz, Olga Esik.   

Abstract

The genotype and phenotype characteristics of Hungarian patients with RET proto-oncogene mutations operated on for hereditary medullary thyroid cancer (MTC) were studied. The genetic screening was performed in two centers and 40 patients with hereditary MTC or C-cell hyperplasia (CCH) from 18 unrelated families were analyzed. One patient having a mutation in exon 16 (Met918Thr) presented with the MEN2B phenotype, six patients from two families had hereditary MTC without pheochromocytoma (pheo) and primary hyperparathyroidism (PHPT), whereas 33 patients from 15 families showed the MEN2A phenotype. Two different mutations were identified in exon 10 (Cys609Tyr and Cys609Ser), five different mutations were present in exon 11 (Cys634Phe, Cys634Arg, Cys634Tyr, Cys634Trp and Cys634Ser), and two different mutations were localized in exon 14 (Val804Met and Val804Leu). Mutations in exon 10 were associated with hereditary MTC (Cys609Tyr) or with MEN2A syndrome (Cys609Ser). Mutations in exon 11 were always associated with the MEN2A phenotype. PHPT was present in one patient with mutation in exon 14 (Val804Met), whereas all other patients affected with mutations in exon 14 had hereditary MTC without PHPT and/or pheos.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16865647     DOI: 10.1007/s00508-006-0635-9

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  19 in total

1.  Genotype-phenotype correlations in hereditary medullary thyroid carcinoma: oncological features and biochemical properties.

Authors:  A Machens; O Gimm; R Hinze; W Höppner; B O Boehm; H Dralle
Journal:  J Clin Endocrinol Metab       Date:  2001-03       Impact factor: 5.958

Review 2.  The phenotypes associated with ret mutations in the multiple endocrine neoplasia type 2 syndrome.

Authors:  B A Ponder
Journal:  Cancer Res       Date:  1999-04-01       Impact factor: 12.701

3.  Adrenal and extra-adrenal pheochromocytomas in a family with germline RET V804L mutation.

Authors:  O Nilsson; L E Tisell; S Jansson; H Ahlman; O Gimm; C Eng
Journal:  JAMA       Date:  1999-05-05       Impact factor: 56.272

4.  A GTG to ATG novel point mutation at codon 804 in exon 14 of the RET proto-oncogene in two families affected by familial medullary thyroid carcinoma.

Authors:  O Fattoruso; L Quadro; A Libroia; U Verga; G Lupoli; E Cascone; V Colantuoni
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

Review 5.  Genetic basis of endocrine disease: multiple endocrine neoplasia type 2.

Authors:  L M Mulligan; B A Ponder
Journal:  J Clin Endocrinol Metab       Date:  1995-07       Impact factor: 5.958

Review 6.  Guidelines for diagnosis and therapy of MEN type 1 and type 2.

Authors:  M L Brandi; R F Gagel; A Angeli; J P Bilezikian; P Beck-Peccoz; C Bordi; B Conte-Devolx; A Falchetti; R G Gheri; A Libroia; C J Lips; G Lombardi; M Mannelli; F Pacini; B A Ponder; F Raue; B Skogseid; G Tamburrano; R V Thakker; N W Thompson; P Tomassetti; F Tonelli; S A Wells; S J Marx
Journal:  J Clin Endocrinol Metab       Date:  2001-12       Impact factor: 5.958

7.  Molecular genetic diagnostic program of multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma syndromes in Hungary.

Authors:  I Klein; O Esik; V Homolya; F Szeri; A Váradi
Journal:  J Endocrinol       Date:  2001-09       Impact factor: 4.286

8.  A new hot spot for mutations in the ret protooncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A.

Authors:  I Berndt; M Reuter; B Saller; K Frank-Raue; P Groth; M Grussendorf; F Raue; M M Ritter; W Höppner
Journal:  J Clin Endocrinol Metab       Date:  1998-03       Impact factor: 5.958

9.  Mutation of RET codon 768 is associated with the FMTC phenotype.

Authors:  L M Boccia; J S Green; C Joyce; C Eng; S A Taylor; L M Mulligan
Journal:  Clin Genet       Date:  1997-02       Impact factor: 4.438

10.  Germline dinucleotide mutation in codon 883 of the RET proto-oncogene in multiple endocrine neoplasia type 2B without codon 918 mutation.

Authors:  O Gimm; D J Marsh; S D Andrew; A Frilling; P L Dahia; L M Mulligan; J D Zajac; B G Robinson; C Eng
Journal:  J Clin Endocrinol Metab       Date:  1997-11       Impact factor: 5.958

View more
  7 in total

Review 1.  Parathyroid hormone-dependent hypercalcemia.

Authors:  Judit Toke; Attila Patócs; Katalin Balogh; Péter Gergics; Balázs Stenczer; Károly Rácz; Miklós Tóth
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

2.  Molecular and clinical analysis of patients with classic and Duarte galactosemia in western Hungary.

Authors:  Ilona Milánkovics; Agnes Schuler; Eniko Kámory; Béla Csókay; Flóra Fodor; Csilla Somogyi; Krisztina Németh; György Fekete
Journal:  Wien Klin Wochenschr       Date:  2010-02       Impact factor: 1.704

3.  RET gene mutations and polymorphisms in medullary thyroid carcinomas in Indian patients.

Authors:  B P Sharma; D Saranath
Journal:  J Biosci       Date:  2011-09       Impact factor: 1.826

4.  Orolabial signs are important clues for diagnosis of the rare endocrine syndrome MEN 2B. Presentation of two unrelated cases.

Authors:  Agnes Sallai; Eva Hosszú; Péter Gergics; Károly Rácz; György Fekete
Journal:  Eur J Pediatr       Date:  2007-06-19       Impact factor: 3.183

5.  Characterization of the largest kindred with MEN2A due to a Cys609Ser RET mutation.

Authors:  Caterina Mian; Susi Barollo; Laura Zambonin; Gianmaria Pennelli; Paolo Bernante; Maria Rosa Pelizzo; Davide Nacamulli; Franco Mantero; Maria Elisa Girelli; Giuseppe Opocher
Journal:  Fam Cancer       Date:  2009-05-28       Impact factor: 2.375

6.  Different RET gene mutation-induced multiple endocrine neoplasia type 2A in 3 Chinese families.

Authors:  Qiuli Liu; Dali Tong; Wenqiang Yuan; Gaolei Liu; Gang Yuan; Weihua Lan; Dianzheng Zhang; Jun Zhang; Zaoming Huang; Yao Zhang; Jun Jiang
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

7.  Primary hyperparathyroidism as first manifestation in multiple endocrine neoplasia type 2A: an international multicenter study.

Authors:  Louise Vølund Larsen; Delphine Mirebeau-Prunier; Tsuneo Imai; Cristina Alvarez-Escola; Kornelia Hasse-Lazar; Simona Censi; Luciana A Castroneves; Akihiro Sakurai; Minoru Kihara; Kiyomi Horiuchi; Véronique Dorine Barbu; Francoise Borson-Chazot; Anne-Paule Gimenez-Roqueplo; Pascal Pigny; Stephane Pinson; Nelson Wohllk; Charis Eng; Berna Imge Aydogan; Dhananjaya Saranath; Sarka Dvorakova; Frederic Castinetti; Attila Patocs; Damijan Bergant; Thera P Links; Mariola Peczkowska; Ana O Hoff; Caterina Mian; Trisha Dwight; Barbara Jarzab; Hartmut P H Neumann; Mercedes Robledo; Shinya Uchino; Anne Barlier; Christian Godballe; Jes Sloth Mathiesen
Journal:  Endocr Connect       Date:  2020-06       Impact factor: 3.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.